Has Holly Hake Harris, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,419,793 in general payments to Holly Hake Harris, MD across 810 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Holly Hake Harris, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Holly Hake Harris, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Holly Hake Harris, MD

Dermatology · South Bend, INNPI 1538159207

Payments from drug & device makers

$3,419,793in general payments, 2019–2025

Across 810 payments — averaging $4221.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$1.8M
Pfizer$424K
Incyte Corporation$375K
AbbVie$335K
E.r. Squibb & Sons, L.L.C.$229K
Acrotech Biopharma Inc.$110K
plus $137K from 9 others

$442,438in research payments, 2019–2025

Across 14 payments — averaging $31,603 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$434K
E.r. Squibb & Sons, L.L.C.$8K

What the payments were for

Travel & lodging$1,71663%
Food & beverage$1,02237%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	82	$1,810,008
Pfizer	106	$424,481
Incyte Corporation	422	$374,587
AbbVie	142	$335,087
E.r. Squibb & Sons, L.L.C.	21	$228,873
Acrotech Biopharma Inc.	15	$109,983
Digital Diagnostics Inc.	7	$109,356
Amgen	2	$27,030
Organogenesis Inc.	2	$148
Lilly USA, LLC	3	$59
Johnson & Johnson	3	$58
Novartis	2	$45
Medline Industries LP	1	$34
Fresenius Kabi USA, LLC	1	$23
Sanofi	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Affinity$125

How this compares

$3,419,793 in reported general payments places this provider in the 95th percentile of 202 dermatology providers in Indiana.

See all dermatology providers in Indiana →

Medicare billing

Part B allowed, 2024

$1,011,858

Medicare patients

691

Services billed

4,305

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	145	$1,073
Mupirocin	157	$1,064
Fluorouracil	11	$805
Doxycycline Hyclate	69	$570
Triamcinolone Acetonide	16	$127
Ciprofloxacin Hcl	18	$73
Minoxidil	11	$72
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	13	$55
Hydrocortisone	11	$31

Paid to pharmacies, not to this prescriber.

Other dermatology in South Bend

Scott GuenthnerPlainfield$10.7M
Scott FretzinIndianapolis$9.8M
David RosmarinIndianapolis$4.4M
Megan LandisCorydon$2.8M
Kenneth DawesIndianapolis$2.2M
Ginat MirowskiIndianapolis$1.8M
Vassilios DimitropoulosMichigan City$1.8M
Christopher ObeimeIndianapolis$907K
Megan VissingNew Albany$884K
Charles HudsonEvansville$589K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →